Citation: | SUN Jundi, ZHANG Ziqiang, HE Shuwang, YAO Jing. Progress on novel pediatric oral solid dosage forms[J]. Journal of China Pharmaceutical University, 2019, 50(6): 631-640. DOI: 10.11665/j.issn.1000-5048.20190601 |
[1] |
Porter J,Withe M,Ross RJ.Immediate-release granule formulation of hydrocortisone,Alkindi®,for treatment of paediatric adrenal insufficiency(Infacort development programme)[J].Expert Rev Endocrinol Metab,2018,13(3):119-124.
|
[2] |
Childress A,Belchenko D,Lempa B.The use of modified-release methylphenidate in the treatment of attention-deficit/hyperactivity disorder[J].Expert Rev Neurother,2017,17(2):113-121.
|
[3] |
Burnside Beth A,Guo XD,Fiske K,et al.Oral pulsed dose drug delivery system:AU,20000012145D[P].2000-05-08.
|
[4] |
Sun Pharmaceutical Industries Limited.Capsule dosage form of metoprolo succinate:US,9504655(B2)[P].2016-11-29.
|
[5] |
Lickrish D,Zhang F.Methods for treatment of attention deficit hyperactivity disorder:US,8916588(B2)[P].2014-12-23.
|
[6] |
Neeraj S,Masayuki I,Takashi M.Multi-unit drug delivery device for pulsatile or sustained release:EP,2586429(A1)[P].2013-05-01.
|
[7] |
Balducci AG,Colombo G,Corace G,et al.Layered lipid microcapsules for mesalazine delayed-release in children[J].Int J Pharm,2011,421(2):293-300.
|
[8] |
Wairkar S,Gaud R,Raghavan A.Multi-particulate systems:cutting-edge technology for controlled drug delivery[J].Recent Pat Drug Deliv Formul,2016,10(3):184-191.
|
[9] |
Han R,Yang YL,Li XS,et al.Predicting oral disintegrating tablet formulations by neural network techniques[J].Asian J Pharm Sci,2018,13(4):336-342.
|
[10] |
Martínez Terán ME,Flament MP.Development of multiparticulate orodispersible tablets for pediatric use[J].Int J Pharm,2016,511(2):1143.
|
[11] |
Hoang Thi TH,Lhafidi S,Carneiro SP,et al.Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use[J].Int J Pharm,2015,496(2):842-849.
|
[12] |
Shang R,Liu C,Quan P,et al.Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release,taste masking and hygroscopicity reduction[J].Int J Pharm,2018,545(1/2):163-169.
|
[13] |
Tengler M,McMahen R.Compositions comprising methylphenidate complexed with ion- exchange resin particles:US,9089496(B2)[P].2015-07-28.
|
[14] |
Elwerfalli AM,Al-Kinani A,Alany RG,et al.Nano-engineering chitosan particles to sustain the release of promethazine from orodispersables[J].Carbohydr Polym,2015,131:447-461.
|
[15] |
Chen YD,Liang ZY,Cen YY,et al.Development of oral dispersible tablets containing prednisolone nanoparticles for the management of pediatric asthma[J].Drug Des Devel Ther,2015,9:5815-5825.
|
[16] |
Elwerfalli AM,Ghanchi Z,Rashid F,et al.New generation of orally disintegrating tablets for sustained drug release:a propitious outlook[J].Curr Drug Deliv,2015,12(6):652-667.
|
[17] |
Visser JC,Woerdenbag HJ,Hanff LM,et al.Personalized medicine in pediatrics:the clinical potential of orodispersible films[J].AAPS PharmSciTech,2017,18(2):267-272.
|
[18] |
Visser JC,Woerdenbag HJ,Crediet S,et al.Orodispersible films in individualized pharmacotherapy:the development of a formulation for pharmacy preparations[J].Int J Pharm,2015,478(1):155-163.
|
[19] |
Zhu Y,You XR,Huang KQ,et al.Effect of taste masking technology on fast dissolving oral film:dissolution rate and bioavailability[J].Nanotechnology,2018,29(30):1-21.
|
[20] |
Ehtezazi T,Algellay M,Islam Y,et al.The application of 3D printing in the formulation of multilayered fast dissolving oral films[J].J Pharm Sci,2018,107(4):1076-1085.
|
[21] |
Soroushnai A,Ganji F,Vasheghani-Farahani E,et al.Development and evaluation of an anti- epileptic oral fast-dissolving film with enhanced dissolution and in vivo permeation[J].Curr Drug Deliv,2018,15(9):1294-1304.
|
[22] |
Pimparade MB,Vo A,Maurya AS,et al.Development and evaluation of an oral fast disintegrating anti-allergic film using hot-melt extrusion technology[J].Eur J Pharm Biopharm,2017,119:81-90.
|
[23] |
Rustemkyzy C,Belton P,Qi S.Preparation and characterization of ultrarapidly dissolving orodispersible films for treating and preventing iodine deficiency in the pediatric population[J].J Agric Food Chem,2015,63(44):9831-9838.
|
[24] |
Hayakawa Y,Uchida S,Namiki N.Evaluation of the ease of taking mini-tablets compared with other tablet formulations in healthy volunteers[J].Eur J Pharm Sci,2016,84:157-161.
|
[25] |
El-Say KM,Ahmed TA,Abdelbary MF,et al.Risperidone oral disintegrating Mini-tablets:a robust-product for pediatrics[J].Acta Pharm,2015,65(4):365-382.
|
[26] |
Aleksovski A,Dreu R,Gaperlin M,et al.Mini-tablets:a contemporary system for oral drug delivery in targeted patient groups[J].Expert Opin Drug Deliv,2015,12(1):65-84.
|
[27] |
Monsuur F,Choudhari Y,Reddy U,et al.Solvent free amorphisation for pediatric formulations(minitablets)using mesoporous silica[J].Int J Pharm,2016,511(2):1135-1136.
|
[28] |
Parissaux X,Druon A,Agnès W,et al.Synergy of maltitol and intense sweetener in taste masking of acetaminophen chewable tablets[J].Int J Pharm,2018,536(2):517-518.
|
[29] |
Dille MJ,Hattrem MN,Draget KI.Soft,chewable gelatin-based pharmaceutical oral formulations:a technical approach[J].Pharm Dev Technol,2018,23(5):504-511.
|
[30] |
Nour SA,Abdelmalak NS,Naguib MJ.Novel chewable colon targeted tablets of bumadizone calcium for treatment of ulcerative colitis:formulation and optimization[J].J Drug Deliv Sci Technol,2016,35:172-183.
|
[31] |
Childress A,Ponce De Leon B,Owens M.QuilliChew extended-release chewable tablets for the treatment of ADHD in patients ages 6 years old and above[J].Expert Opin Drug Deliv,2018,15(12):1263-1270.
|
[32] |
Al Hagbani T,Nazzal S.Medicated chewing gums(MCGs):composition,production,and mechanical testing[J].AAPS PharmSciTech,2018,19(7):2908-2920.
|
[33] |
Al Hagbani T,Altomare C,Kamal MM,et al.Mechanical characterization and dissolution of chewing gum tablets(CGTs)containing co-compressed health in gum® and curcumin/cyclodextrin inclusion complex[J].AAPS PharmSciTech,2018,19(8):3742-3750.
|
[34] |
Mohammadi N,Ehsani MR,Bakhoda H.Design and evaluation of the release characteristics of caffeine-loaded microcapsules in a medicated chewing gum formulation[J].Food Biophys,2018,13(3):240-249.
|
[35] |
Buck J,Huwyler J,Kühl P,et al.Pediatric dispersible tablets:a modular approach for rapid prototyping[J].Pharm Res,2016,33(8):2043-2055.
|
[36] |
Lal M,Lai M,Estrada M,et al.Developing a flexible pediatric dosage form for antiretroviral therapy:a fast-dissolving tablet[J].J Pharm Sci,2017,106(8):2173-2177.
|
[37] |
Tian P,Yang F,Xu Y,et al.Oral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing[J].Drug Dev Ind Pharm,2018,44(12):1918-1923.
|
[38] |
Chandrasekaran P, Kandasamy R. Development of extended-release oral flexible tablet(ER-OFT)formulation for pediatric and geriatric compliance:an age-appropriate formulation[J].AAPS PharmSciTech,2017,18(7):2394-2409.
|
[39] |
Cantor SL,Khan MA,Gupta A.Development and optimization of taste-masked orally disintegrating tablets(ODTs)of clindamycin hydrochloride[J].Drug Dev Ind Pharm,2015,41(7):1156-1164.
|
[40] |
Chandrasekaran P,Kandasamy R.Development of oral flexible tablet(OFT)formulation for pediatric and geriatric patients:a novel age-appropriate formulation platform[J].AAPS PharmSciTech,2017,18(6):1972-1986.
|
[41] |
Lin W,Yan JH,Heimbach T,et al.Pediatric physiologically based pharmacokinetic model development:current status and challenges[J].Curr Pharmacol Rep,2018,4(6):491-501.
|
[42] |
Wang DD,Lu JM,Li YZ,et al.Population pharmacokinetics of sirolimus in pediatric tuberous sclerosis complex:from real world study[J].Int J Clin Exp Med.2018,11(11):12302-12309.
|
[1] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[2] | LUO Xuelian, WU Chengsheng, ZHA Cheng, LIU Sheng. Research progress and prospects of implantable drug delivery systems for postoperative tumor therapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 538-547. DOI: 10.11665/j.issn.1000-5048.2024040901 |
[3] | WANG Shihao, LIU Lifeng, DING Yang, LI Suxin. Research progress of pH-responsive drug delivery systems in cancer immunotherapy[J]. Journal of China Pharmaceutical University, 2024, 55(4): 522-529. DOI: 10.11665/j.issn.1000-5048.2024011902 |
[4] | YU Jiayu, LIN Zezhi, CAO Wei, ZHANG Jianjun, WEI Yuanfeng, GAO Yuan, QIAN Shuai. Research progress of bio-metal organic frameworks in drug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 23-33. DOI: 10.11665/j.issn.1000-5048.20221111003 |
[5] | ZHOU Yeshu, WANG Yanmei, ZHANG Beiyuan, WU Shuaicong, YANG Lei, YIN Lifang. Research progress of inorganic nanomaterials in drug delivery system[J]. Journal of China Pharmaceutical University, 2020, 51(4): 394-405. DOI: 10.11665/j.issn.1000-5048.20200403 |
[6] | LI Haoxian, LIN Huaqing, CHEN Jingwen, WANG Liyuan. Research progress of carbon nanomaterials in cancer drug delivery[J]. Journal of China Pharmaceutical University, 2019, 50(1): 100-106. DOI: 10.11665/j.issn.1000-5048.20190114 |
[7] | FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302 |
[8] | CHEN Xing, KANG Yang, WU Jun. Advances in biodegradable functional polymers based protein drug delivery system[J]. Journal of China Pharmaceutical University, 2017, 48(2): 142-149. DOI: 10.11665/j.issn.1000-5048.20170203 |
[9] | WANG Yazhe, ZHOU Jianping, DING Yang, WANG Wei. Advances in research of biomimetic drug delivery systems[J]. Journal of China Pharmaceutical University, 2014, 45(3): 267-273. DOI: 10.11665/j.issn.1000-5048.20140303 |
[10] | TANG Yue, KE Xue. Advances of mesoporous silica nanoparticles as drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(6): 567-572. |